Neda Alrawashdh

4PUBLICATIONS
3CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 28, 2022
Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer.

Neda Alrawashdh, Jamie Vraney, Briana M Choi

|Nov 08, 2021
Expanded access to anticancer treatments from conversion to biosimilar pegfilgrastim-cbqv in US breast cancer patients.

Ali McBride, Neda Alrawashdh, Karen MacDonald

|Aug 12, 2021
Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer.

Karen MacDonald, Neda Alrawashdh, Ali McBride

|Jul 09, 2021
Same-day versus next-day pegfilgrastim or pegfilgrastim-cbqv in patients with lymphoma receiving CHOP-like chemotherapy.

Ali McBride, Neda Alrawashdh, Trace Bartels

Pageof 1